Clinical trial
Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor…
NCT00238732 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00238732 |
|---|---|
| Title | Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause |
| Official title | A Double-Blind, Randomized, Placebo-and Active-Controlled Efficacy and Safety Study of Bazedoxifene/Conjugated Estrogens Combinations for Treatment of Moderate to Severe Vulvar/Vaginal Atrophy in Postmenopausal Women |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vaginal Atrophy |
| Intervention type | Drug |
| Interventions | Bazedoxifene/Conjugated Estrogen |
| Enrollment | 650 |
| Start date | Oct 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Oct 13, 2005 |
| Last update posted | Dec 28, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: